Evidence map›Paper›PMID 35572713›Full record

ArticleFrontiers in microbiology2022

Lactobacillus Modulates Chlamydia Infectivity and Genital Tract Pathology

Hongliang Chen, Shuling Min, Li Wang, Lanhua Zhao, Fangzhen Luo, Wenbo Lei, Yating Wen, Lipei Luo, Qianting Zhou, Lixiu Peng and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Frontiers in cellular and infection microbiology · 2026
    Review
  3. Article
  4. Disrupted Cervicovaginal Microbiota: Its Role inInternational journal of molecular sciences · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Influence of cervicovaginal microbiota onMicrobial cell (Graz, Austria) · 2025
    Review
  9. Identifying the Impact ofPathogens (Basel, Switzerland) · 2024
    Article
  10. Review
  11. Anti-chlamydial activity of vaginal fluids: new evidence from anFrontiers in cellular and infection microbiology · 2024
    Article
  12. Article
  13. Role of D(-)-Lactic Acid in Prevention ofPathogens (Basel, Switzerland) · 2023
    Article
  14. Fabrication and characterization of bioprints with Lactobacillus crispatus for vaginal application.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  15. Review
  16. Use of probiotic lactobacilli in the treatment of vaginal infections:Frontiers in cellular and infection microbiology · 2023
    Review
  17. Impact of aFrontiers in cellular and infection microbiology · 2023
    Article
  18. Interactions between microbiota and cervical epithelial, immune, and mucus barrier.Frontiers in cellular and infection microbiology · 2023
    Review
  19. Review
  20. The role of tryptophan inFrontiers in cellular and infection microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Hongliang ChenChenzhou No.1 People's Hospital, Hengyang Medical School, University of South China, Chenzhou, China.
Shuling MinChenzhou No.1 People's Hospital, Hengyang Medical School, University of South China, Chenzhou, China.
Li WangChenzhou No.1 People's Hospital, The First School of Clinical Medicine, Southern Medical University, Chenzhou, China.
Lanhua ZhaoInstitute of Pathogenic Biology, Hengyang Medical College, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, China.
Fangzhen LuoInstitute of Pathogenic Biology, Hengyang Medical College, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, China.
Wenbo LeiInstitute of Pathogenic Biology, Hengyang Medical College, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, China.
Yating WenInstitute of Pathogenic Biology, Hengyang Medical College, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, China.
Lipei LuoChenzhou No.1 People's Hospital, The First School of Clinical Medicine, Southern Medical University, Chenzhou, China.
Qianting ZhouChenzhou No.1 People's Hospital, Hengyang Medical School, University of South China, Chenzhou, China.
Lixiu PengChenzhou No.1 People's Hospital, Hengyang Medical School, University of South China, Chenzhou, China.
Zhongyu LiInstitute of Pathogenic Biology, Hengyang Medical College, Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, China.
University of South China · CNSouthern Medical University · CNChenzhou First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since we previously reported that women infected with chlamydia had a significant overall reduction in Lactobacillus in the vagina microbiota as compared to those uninfected individuals; the interactions between the altered Lactobacillus and

Indexed as

chlamydiaD (–) lactic acidinfectivitylactobacilluspathology

Identifiers

PMID35572713
PMCPMC9098263
OpenAlexW4285741327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.